BackgroundSYNTAX is a randomized controlled trial comparing percutaneous coronary intervention (PCI) using drug-eluting stents with coronary artery bypass graft surgery (CABG) in patients (pts) with 3 vessel and/or left main disease. We will analyze health economic data associated with CABG and PCI in the subset of France compared with select countries in the EU (Germany, Italy and UK).MethodsCosts will be estimated using 1-year resource utilization data including procedural resource use (stents, guidewires etc.), hospitalizations major procedures and work days lost. Estimates are based on French patterns of resource utilization, number of hospital days and break down of those in intensive care, or ward days. Where data did not allow reliab...
We analyse variations in costs or lengths of stay (LoS) for 66,587 patients from ten European countr...
Coronary artery disease (CAD) has significant social and economic implications. It is necessary to c...
Objectives: To evaluate the cost-effectiveness of alternative approaches to revasculari-zation for p...
BackgroundSYNTAX is a randomized controlled trial comparing percutaneous coronary intervention (PCI)...
Aims Recent cost-effectiveness analyses of percutaneous coronary intervention (PCI) versus coronary ...
textabstractObjectives: To evaluate the cost-effectiveness of alternative approaches to revasculariz...
Objectives: To compare initial and one year costs of coronary artery bypass grafting (CABG) versus p...
SummaryBackgroundFew studies have analyzed the cost of treatment of chronic angina pectoris, especia...
313-27BACKGROUND: There has been a steep increase in the number of percutaneous coronary interventio...
Background: There are limited economic evaluations comparing coronary artery bypass grafting (CABG) ...
Purpose The Zilver PTX drug-eluting stent (Cook Ireland Ltd., Limerick, Ireland) represents an advan...
compare the clinical results of the best technology of percutaneous coronary interventions (PCI) usi...
International audienceIntroduction: The European Medicines Agency restored aprotinin (APR) use for p...
Aims: The suitability of percutaneous coronary intervention (PCI), compared with coronary artery byp...
Objective: To evaluate the cost-effectiveness of percutaneous coronary intervention (PCI) compared w...
We analyse variations in costs or lengths of stay (LoS) for 66,587 patients from ten European countr...
Coronary artery disease (CAD) has significant social and economic implications. It is necessary to c...
Objectives: To evaluate the cost-effectiveness of alternative approaches to revasculari-zation for p...
BackgroundSYNTAX is a randomized controlled trial comparing percutaneous coronary intervention (PCI)...
Aims Recent cost-effectiveness analyses of percutaneous coronary intervention (PCI) versus coronary ...
textabstractObjectives: To evaluate the cost-effectiveness of alternative approaches to revasculariz...
Objectives: To compare initial and one year costs of coronary artery bypass grafting (CABG) versus p...
SummaryBackgroundFew studies have analyzed the cost of treatment of chronic angina pectoris, especia...
313-27BACKGROUND: There has been a steep increase in the number of percutaneous coronary interventio...
Background: There are limited economic evaluations comparing coronary artery bypass grafting (CABG) ...
Purpose The Zilver PTX drug-eluting stent (Cook Ireland Ltd., Limerick, Ireland) represents an advan...
compare the clinical results of the best technology of percutaneous coronary interventions (PCI) usi...
International audienceIntroduction: The European Medicines Agency restored aprotinin (APR) use for p...
Aims: The suitability of percutaneous coronary intervention (PCI), compared with coronary artery byp...
Objective: To evaluate the cost-effectiveness of percutaneous coronary intervention (PCI) compared w...
We analyse variations in costs or lengths of stay (LoS) for 66,587 patients from ten European countr...
Coronary artery disease (CAD) has significant social and economic implications. It is necessary to c...
Objectives: To evaluate the cost-effectiveness of alternative approaches to revasculari-zation for p...